U.S. Industrials Stock News

What recent performance says about Itron (ITRI) today Itron (ITRI) has come under pressure recently, with the share price showing a 2.2% decline over the past day and a 5.6% pullback over the past week, extending weakness over the past month. See our latest analysis for Itron. The recent 30 day share price return of a 6.2% decline and the year to date share price return, which is close to flat, sit against a 1 year total shareholder return of a 13.7% decline. This hints that momentum has...

If you are wondering whether Toast's current share price gives you enough value for the risk you are taking on, it helps to line up what the market is paying today against what the business might be worth using a few different valuation lenses. Toast finished the last trading session at US$27.31, with returns of 0.9% over the past 7 days, a 14.3% decline over 30 days, a 19.7% decline year to date, a 29.2% decline over 1 year, and a 45.3% gain over 3 years, which gives a mixed picture of how...

If you are wondering whether 3M is still a solid value play at its current price, this article walks through what the numbers actually say about the stock. 3M shares last closed at US$165.32, with a 1% decline over the past week, a 6% gain over the last 30 days, and returns of 2.2% year to date, 8.5% over 1 year, a very large gain over 3 years, and 31% over 5 years. Recent headlines around 3M have focused on its ongoing business repositioning and legal overhangs, which continue to shape how...

In late February 2026, Globus Medical reported record Q4 2025 and full-year 2025 results, with sales rising to US$826.42 million for the quarter and US$2.94 billion for the year, and net income increasing to US$140.59 million and US$537.87 million respectively. Management reaffirmed 2026 revenue guidance of US$3.18 billion to US$3.22 billion while lifting non-GAAP EPS expectations and highlighting faster-than-planned benefits from the Nevro acquisition, underscoring how recent M&A and...

Perfect (PERF) has drawn fresh attention after partnering with True Beauty Lashes on LashLovr, an AI powered lash matching and virtual try on experience that highlights how its APIs are used in real retail journeys. See our latest analysis for Perfect. Even with the LashLovr partnership and recent earnings update, Perfect’s short term share price return has been weak, with a 30 day share price decline of 18.67% and a 1 year total shareholder return of 28.19% in the red. This points to fading...

Perrigo (NYSE:PRGO) has announced a new operational enhancement program after reporting significant progress on its Three-S transformation approach. The company highlighted a tripling in the value of its innovation pipeline and more than US$100 million in new distribution wins. Perrigo also reported a major net loss for the fourth quarter and full year, linked in part to an asset impairment charge. Management described 2026 as a transition year, citing manufacturing under-absorption, and is...

nLIGHT (LASR) has wrapped up FY 2025 with Q4 revenue of US$81.2 million and a basic EPS loss of US$0.10, alongside trailing twelve month revenue of US$261.3 million and a basic EPS loss of US$0.47. The company has seen quarterly revenue move from US$47.4 million in Q4 2024 to US$81.2 million in Q4 2025, while basic EPS over the same quarters shifted from a loss of US$0.51 to a loss of US$0.10. This leaves investors to weigh growth expectations against still negative margins and the path to...

National Health Investors (NHI) closed out FY 2025 with Q4 revenue of US$107.5 million and basic EPS of US$0.80, alongside funds from operations of US$58.5 million, which is a key earnings measure for healthcare REIT investors. The company reported quarterly revenue of US$85.8 million in Q4 2024 and US$107.5 million in Q4 2025, while basic EPS moved from US$0.96 to US$0.80 over the same period, providing a view of how the top line and earnings per share have developed into the latest release...

If you are wondering whether Philip Morris International (NYSE: PM) still offers value at around US$186.83 a share, you are not alone. This article is built to help you make sense of that question. The stock has returned 1.9% over the past week, 4.6% over the past month, 16.6% year to date and 24.6% over the past year, with a very large 3 year return and a very large 5 year return that many investors are trying to put into context. Recent headlines around Philip Morris International have...

Fresh off its Q2 2026 print, Zscaler (ZS) reported revenue of US$815.8 million and a basic EPS loss of US$0.21, with net income excluding extra items at a loss of US$34.3 million, setting the tone for how investors will read the quarter. The company has seen revenue move from US$647.9 million in Q2 2025 through to US$815.8 million in Q2 2026, while quarterly basic EPS over that stretch has ranged from a loss of US$0.05 in Q2 2025 to a loss of US$0.21 in the latest quarter. As a result, the...

FirstSun Capital Bancorp (NasdaqGS:FSUN) has received Office of the Comptroller of the Currency approval for its planned merger with First Foundation Inc. The merger remains subject to Federal Reserve approval and shareholder votes from both companies. If completed, the transaction is expected to significantly expand the combined bank's operations and product platform. FirstSun Capital Bancorp, a regional banking platform focused on commercial and consumer clients, is moving through a key...

Schrödinger, Inc. reported full-year 2025 results, with sales of US$56.37 million and total revenue of US$255.87 million, while reducing its net loss to US$103.27 million and basic loss per share from continuing operations to US$1.41. The combination of strong revenue growth and a substantially smaller loss suggests the company is scaling its platform while exercising tighter cost control. We’ll now examine how this sharp revenue increase and narrower loss shape Schrödinger’s existing...

IPG Photonics (NasdaqGS:IPGP) has received an adverse ruling from the Unified Patent Court in Germany in a patent infringement case with Trumpf SE & Co. KG involving adjustable mode beam lasers. The decision may lead to an injunction, product recall, or damages affecting certain products in key European markets. In parallel, the company announced a substantial follow on order from Lockheed Martin for its CROSSBOW counter UAS laser systems. At a share price of $131.57, IPG Photonics comes...

If you are wondering whether Sociedad Química y Minera de Chile shares are still offering value at current levels, this article is here to unpack what the current price might be implying about the business. The stock last closed at US$76.30, with a 6.2% return over the past 7 days, a 9.4% return year to date, a 98.9% return over 1 year, a 71.6% return over 5 years and an 8.7% decline over 30 days. This can naturally raise questions about where expectations and risks now sit. Recent headlines...

Western Midstream Partners (WES) is back in focus after its fourth quarter 2025 results missed earnings and revenue forecasts, even as management paired the release with record full-year adjusted EBITDA and higher 2026 distribution guidance. See our latest analysis for Western Midstream Partners. At a share price of $41.59, Western Midstream Partners has seen steady momentum, with a 90 day share price return of 5.75% and a 1 year total shareholder return of 12.53%, building on a very large 5...

Graphic Packaging Holding (GPK) has quickly come into focus after amending its credit agreement to allow higher leverage, while also facing legal investigations linked to projected 2026 Adjusted EBITDA pressure and prior share price weakness. See our latest analysis for Graphic Packaging Holding. The leverage covenant change, legal investigations, and recent dividend declaration all come against a backdrop of weaker share price momentum, with a 30 day share price return of 17.59% and a 1 year...

What recent returns tell you about Arch Capital Group (ACGL) Arch Capital Group (ACGL) has drawn fresh attention after a steady run, with the stock showing gains over the past week, month, past 3 months, year to date, and the past year. Over longer stretches, its reported 3 year and 5 year total returns are also positive, which helps frame the current share price of $100.15 that investors are reacting to today. See our latest analysis for Arch Capital Group. For context, Arch Capital Group’s...

If you are wondering whether Parker-Hannifin's current share price still offers value, this article walks through what the numbers are saying about the stock today. The shares recently closed at US$1,009.18, with returns of 10.1% over the last 30 days, 12.9% year to date, and 52.4% over 1 year, while the 3 year and 5 year returns sit at 190.3% and 259.2% respectively. This follows a 1.3% decline over the past week. Recent coverage has focused on Parker-Hannifin as a large US capital goods...

CarMax, NYSE:KMX, has launched a vehicle shopping app in the ChatGPT app store, positioning itself as the first U.S. auto retailer to offer a dedicated conversational AI car buying and selling experience. The new app allows users to search, compare, and explore CarMax’s nationwide inventory using natural language directly within ChatGPT. The move is aimed at aligning the car buying process with changing consumer habits around digital and AI assisted shopping. CarMax enters this launch with...

If you are wondering whether Cardinal Health's share price still reflects fair value after its strong run, you are not alone. This article will walk through what the current numbers might be telling you. The stock last closed at US$229.23, with returns of 2.1% over 7 days, 9.0% over 30 days, 11.4% year to date, 79.3% over 1 year and 221.6% over 3 years. This naturally raises questions about how much of the story is already priced in. Recent news flow around Cardinal Health has focused on its...

Supernus Pharmaceuticals reported record revenues in 2025. The company completed the integration of Sage Therapeutics. New products ONAPGO for Parkinson's disease and ZURZUVAE for postpartum depression were launched. The business expanded into new therapeutic areas despite supply constraints. For investors looking at NasdaqGM:SUPN, these company updates come with a stock that last closed at $54.73 and has returned 70.7% over the past year. Over 3 years the stock is up 37.5%, and over 5...

If you are wondering whether Trustmark's current share price lines up with its underlying value, this article is designed to walk you through that question in a clear, practical way. Trustmark's share price recently closed at US$42.59, with returns of a 4.8% decline over 7 days, 1.1% over 30 days, 9.0% year to date, 19.3% over 1 year, 59.7% over 3 years and 48.4% over 5 years. These price moves are sitting against a backdrop of ongoing interest in US regional banks. In this space, investors...

Sunrun (RUN) closed out FY 2025 with Q4 revenue of US$1.2 billion and basic EPS of US$0.45, while trailing twelve month EPS sat at US$1.96 on revenue of US$3.0 billion. The company has seen quarterly revenue range from US$504.3 million to US$1.2 billion through 2025, with basic EPS moving from US$0.22 in Q1 to US$1.22 in Q2 and US$0.07 in Q3 before landing at US$0.45 in Q4, alongside a trailing twelve month net income of US$449.9 million. For investors, the key question now is how durable...

If you are wondering whether Dycom Industries' share price still lines up with its underlying worth, this article will walk through what the current market price might be implying about the business. The stock recently closed at US$418.24, with returns of 13.0% over the last 30 days, 20.3% year to date, 155.2% over 1 year, 313.6% over 3 years and 377.8% over 5 years. This raises fair questions about how much optimism is already priced in. Recent news coverage has focused on Dycom Industries'...